Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO C
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Haematologica, 83(2), 1998, pp. 132-137
Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
BREGANTE S
BERISSO G
MORDINI N
INCAGLIATO M
FUGAZZA G
SESSAREGO M
BACIGALUPO A
Citation: P. Zikos et al., ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HIGH-RISK ACUTE LYMPHOBLASTIC-LEUKEMIA - FAVORABLE IMPACT OF CHRONIC GRAFT-VERSUS-HOST DISEASE ON SURVIVAL AND RELAPSE, Haematologica, 83(10), 1998, pp. 896-903
Authors:
BACIGALUPO A
VANLINT BM
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
ZIKOS P
LOMBARDI A
Citation: A. Bacigalupo et al., EARLY PREDICTORS OF TRANSPLANT-RELATED MORTALITY (TRM) AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - BLOOD UREA NITROGEN AND BILIRUBIN, Experimental hematology, 26(8), 1998, pp. 368-368
Authors:
MARINA P
PIAGGIO G
FRASSONI F
PITTO A
ZIKOS P
SESSAREGO M
ABATE M
VANLINT MT
BERISSO G
BACIGALUPO A
Citation: P. Marina et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY (IS) OR BONE-MARROW TRANSPLANTATION (BMT) IN SEVERE APLASTIC-ANEMIA, Experimental hematology, 26(8), 1998, pp. 415-415
Authors:
BACIGALUPO A
ZIKOS P
VANLINT MT
VALBONESI M
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BREGANTE S
BERISSO G
VITALE V
SESSAREGO M
MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Experimental hematology, 26(5), 1998, pp. 409-414
Authors:
MORETTI S
ZIKOS P
VANLINT MT
TEDONE E
OCCHINI D
GUALANDI F
LAMPARELLI T
MORDINI N
BERISSO G
BREGANTE S
BRUNO B
BACIGALUPO A
Citation: S. Moretti et al., FOSCARNET VS GANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) ANTIGENEMIA AFTER ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTATION (HSCT) - A RANDOMIZED STUDY, Bone marrow transplantation, 22(2), 1998, pp. 175-180
Authors:
ZIKOS P
VANLINT MT
FRASSONI F
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINE VS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Bone marrow transplantation, 21, 1998, pp. 38-38
Authors:
BACIGALUPO A
ZIKOS P
VANLINT MT
VALBONESI M
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BREGANTE S
BERISSO G
VITALE V
SESSAREGO M
MARMONT AM
Citation: A. Bacigalupo et al., ALLOGENEIC BONE-MARROW OR PERIPHERAL-BLOOD CELL TRANSPLANTS IN ADULTSWITH HEMATOLOGIC MALIGNANCIES - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 40-40
Authors:
BACIGALUPO A
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
LOMBARDI A
ZIKOS P
Citation: A. Bacigalupo et al., UNMANIPULATED TRANSPLANTS FROM 1-2-ANTIGEN MISMATCHED FAMILY DONORS, Bone marrow transplantation, 21, 1998, pp. 121-121
Authors:
BACIGALUPO A
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
LOMBARDI A
ZIKOS P
Citation: A. Bacigalupo et al., THIOTEPA CYCLOPHOSPHAMIDE (THIO-CY) AS CONDITIONING REGIMEN FOR ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT) - REDUCING THE DOSE FOR PATIENTS AGED 45 TO 60 YEARS, Bone marrow transplantation, 21, 1998, pp. 357-357
Authors:
ZIKOS P
VANLINT MT
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
BACIGALUPO A
Citation: P. Zikos et al., A RANDOMIZED TRIAL OF HIGH-DOSE POLYVALENT INTRAVENOUS IMMUNOGLOBULIN(HDIGG) VS. CYTOMEGALOVIRUS (CMV) HYPERIMMUNE IGG IN ALLOGENEIC HEMATOPOIETIC STEM-CELL TRANSPLANTS (HSCT), Bone marrow transplantation, 21, 1998, pp. 490-490
Authors:
ZIKOS P
VANLINT MT
FRASSONI F
LAMPARELLI T
GUALANDI F
OCCHINI D
MORDINI N
BERISSO G
BREGANTE S
DESTEFANO F
SORACCO M
VITALE V
BACIGALUPO A
Citation: P. Zikos et al., LOW TRANSPLANT MORTALITY IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOID-LEUKEMIA - A RANDOMIZED STUDY OF LOW-DOSE CYCLOSPORINEVERSUS LOW-DOSE CYCLOSPORINE AND LOW-DOSE METHOTREXATE, Blood, 91(9), 1998, pp. 3503-3508
Authors:
PODESTA M
PIAGGIO G
FRASSONI F
PITTO A
ZIKOS P
SESSAREGO M
ABATE M
VANLINT MT
BERISSO G
BACIGALUPO A
Citation: M. Podesta et al., THE ASSESSMENT OF THE HEMATOPOIETIC RESERVOIR AFTER IMMUNOSUPPRESSIVETHERAPY OR BONE-MARROW TRANSPLANTATION IN SEVERE APLASTIC-ANEMIA, Blood, 91(6), 1998, pp. 1959-1965
Authors:
LAMPARELLI T
VANLINT MT
GUALANDI F
OCCHINI D
BARBANTI M
SACCHI N
FICAI G
GHINATTI C
FERRARA GB
DELFINO L
POZZI S
MORABITO A
ZIKOS P
VITALE V
CORVO R
FRASSONI F
BACIGALUPO A
Citation: T. Lamparelli et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML) FROM UNRELATED AND SIBLING DONORS - SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 20(12), 1997, pp. 1057-1062
Authors:
PODESTA M
PIAGGIO G
PITTO A
FUGAZZA G
MORDINI N
BERISSO G
SORACCO M
SESSAREGO M
ZIKOS P
BACIGALUPO A
FRASSONI F
Citation: M. Podesta et al., RELAPSE AFTER ALLOGENEIC BMT FOR CML MAY BE SUSTAINED BY A LOW NUMBEROF LEUKEMIC STEM-CELLS, Blood, 90(10), 1997, pp. 4011-4011
Authors:
UASSILAKOS P
MASTORAKOU A
APOSTOLOPOULOS D
GIANNAKENAS C
ZIKOS P
PAGONIS S
AKTIPI A
GROUZI E
LEBESSOPOULOS C
FRANGOPANAGOU E
TINIAKOU M
PETSAS T
MATSOUKA P
ZOUMBOS N
Citation: P. Uassilakos et al., THE CONTRIBUTION OF SCINTIGRAPHIC IMAGING WITH IN-111 OCTREOTIDE IN THE STAGING OF LYMPHOMAS - A COMPARISON TO OTHER IMAGING MODALITIES, Blood, 84(10), 1994, pp. 10000233-10000233